$3.28
0.3511.95%
Ult. Agg.: Oct 28, 8:19 AM
Anixa Biosciences (ANIX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.10 | $-0.09 | $-0.09 |
| Actual | $-0.08 | $-0.07 | $-0.08 | $-0.09 |
| Surprise | 0.00% | +30.0% | +11.1% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.08 | $-0.08 | $-0.08 | $-0.08 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Sep 9, 2026 | $-0.08 | $-0.08 | 0.00 % |
| Q2 | Jun 10, 2026 | $-0.07 | $-0.10 | 30.0 % |
| Q1 | Mar 9, 2026 | $-0.08 | $-0.09 | 11.1 % |
| Q4 | Jan 12, 2026 | $-0.09 | $-0.09 | 0.00 % |